The European Medicines Agency Review of Ofatumumab (Arzerra®) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of th...

Por Gravanis, Iordanis, Ersbøll, Jens, Skovlund, Eva, Abadie, Eric, Marty, Michel, Pignatti, Francesco
Publicado em 2010

Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors

Por Achour, Abla, Baychelier, Florence, Marty, Michel, Debré, Patrice, Samuel, Didier, Vieillard, Vincent
Publicado em 2014

NF-kappa B genes have a major role in Inflammatory Breast Cancer

Por Lerebours, Florence, Vacher, Sophie, Andrieu, Catherine, Espie, Marc, Marty, Michel, Lidereau, Rosette, Bieche, Ivan
Publicado em 2008

Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action

Por Khorana, Alok A., Streiff, Michael B., Farge, Dominique, Mandala, Mario, Debourdeau, Philippe, Cajfinger, Francis, Marty, Michel, Falanga, Anna, Lyman, Gary H.
Publicado em 2009

In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients

Por Cohen-Haguenauer, Odile, Péault, Bruno, Bauche, Cécile, Daniel, Marie-Thérèse, Casal, Ibrahim, Levy, Vincent, Dausset, Jean, Boiron, Michel, Auclair, Christian, Gluckman, Eliane, Marty, Michel
Publicado em 2006

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study

Por Bidard, François-Clément, Belin, Lisa, Delaloge, Suzette, Lerebours, Florence, Ngo, Charlotte, Reyal, Fabien, Alran, Séverine, Giacchetti, Sylvie, Marty, Michel, Lebofsky, Ronald, Pierga, Jean-Yves
Publicado em 2013

Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers

Por Lehmann-Che, Jacqueline, André, Fabrice, Desmedt, Christine, Mazouni, Chafika, Giacchetti, Sylvie, Turpin, Elisabeth, Espié, Marc, Plassa, Louis-François, Marty, Michel, Bertheau, Philippe, Sotiriou, Christos, Piccart, Martine, Symmans, W. Fraser, Pusztai, Lajos, de Thé, Hugues
Publicado em 2010

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen

Por Bertheau, Philippe, Turpin, Elisabeth, Rickman, David S, Espié, Marc, de Reyniès, Aurélien, Feugeas, Jean-Paul, Plassa, Louis-François, Soliman, Hany, Varna, Mariana, de Roquancourt, Anne, Lehmann-Che, Jacqueline, Beuzard, Yves, Marty, Michel, Misset, Jean-Louis, Janin, Anne, de Thé, Hugues
Publicado em 2007

Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breas...

Por de Cremoux, Patricia, Valet, Fabien, Gentien, David, Lehmann-Che, Jacqueline, Scott, Véronique, Tran-Perennou, Carine, Barbaroux, Catherine, Servant, Nicolas, Vacher, Sophie, Sigal-Zafrani, Brigitte, Mathieu, Marie-Christine, Bertheau, Philippe, Guinebretière, Jean-Marc, Asselain, Bernard, Marty, Michel, Spyratos, Frédérique
Publicado em 2011